메뉴 건너뛰기




Volumn 27, Issue 6, 2012, Pages 785-792

Molecular characterization of EGFR and EGFR-downstream pathways in triple negative breast carcinomas with basal like features

Author keywords

Basal like features; Breast cancers; EGFR; EGFR targeted therapy; Fluorescent in situ hybridization; PTEN; Triple negative

Indexed keywords

ANTINEOPLASTIC AGENT; B RAF KINASE; BRAF PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HER2 PROTEIN, HUMAN; HRAS PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PIK3CA PROTEIN, HUMAN; PROGESTERONE RECEPTOR; PROTEIN KINASE INHIBITOR; PROTEIN P21; PTEN PROTEIN, HUMAN; RAS PROTEIN;

EID: 84859369029     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (57)

References (40)
  • 1
    • 35548956906 scopus 로고    scopus 로고
    • PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma
    • Abubaker J., Bavi P.P., Al-Harbi S., Siraj A.K., Al-Dayel F., Uddin S. and Al-Kuraya K. (2007). PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma. Leukemia 21, 2368-2370.
    • (2007) Leukemia , vol.21 , pp. 2368-2370
    • Abubaker, J.1    Bavi, P.P.2    Al-Harbi, S.3    Siraj, A.K.4    Al-Dayel, F.5    Uddin, S.6    Al-Kuraya, K.7
  • 3
    • 3042785708 scopus 로고    scopus 로고
    • Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: Variation in staining intensity due to choice of fixative and storage time of tissue sections
    • Atkins D., Reiffen K.A., Tegtmeier C.L., Winther H., Bonato M.S. and Störkel S. (2004). Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J. Histochem. Cytochem. 52, 893-901.
    • (2004) J. Histochem. Cytochem , vol.52 , pp. 893-901
    • Atkins, D.1    Reiffen, K.A.2    Tegtmeier, C.L.3    Winther, H.4    Bonato, M.S.5    Störkel, S.6
  • 5
    • 53949104487 scopus 로고    scopus 로고
    • Anti-epidermal growth factor receptor strategies for advanced breast cancer
    • Campos S.M. (2008). Anti-epidermal growth factor receptor strategies for advanced breast cancer. Cancer Invest. 26, 757-768.
    • (2008) Cancer Invest , vol.26 , pp. 757-768
    • Campos, S.M.1
  • 6
    • 40949121882 scopus 로고    scopus 로고
    • Basal-like breast cancer defined by five biomarkers has superior prognostic value than triplenegative phenotype
    • Cheang M.C., Voduc D., Bajdik C., Leung S., McKinney S., Chia S.K., Perou C.M. and Nielsen T.O. (2008). Basal-like breast cancer defined by five biomarkers has superior prognostic value than triplenegative phenotype. Clin. Cancer. Res. 14, 1368-1376.
    • (2008) Clin. Cancer. Res , vol.14 , pp. 1368-1376
    • Cheang, M.C.1    Voduc, D.2    Bajdik, C.3    Leung, S.4    McKinney, S.5    Chia, S.K.6    Perou, C.M.7    Nielsen, T.O.8
  • 8
    • 40849147041 scopus 로고    scopus 로고
    • EGFR antagonists in cancer treatment
    • Ciardiello F. and Tortora G. (2008). EGFR antagonists in cancer treatment. N. Engl. J. Med. 358, 1160-1174.
    • (2008) N. Engl. J. Med , vol.358 , pp. 1160-1174
    • Ciardiello, F.1    Tortora, G.2
  • 11
  • 15
    • 78650630648 scopus 로고    scopus 로고
    • Candidate predictive biomarkers of cetuximab benefit in triplenegative breast cancer
    • (suppl; abstr 1056)
    • Khambata-Ford S., O'Shaughnessy J. and Brickman D. (2010). Candidate predictive biomarkers of cetuximab benefit in triplenegative breast cancer. J. Clin. Oncol. 28, 15s (suppl; abstr 1056).
    • (2010) J. Clin. Oncol , vol.28
    • Khambata-Ford, S.1    O'Shaughnessy, J.2    Brickman, D.3
  • 16
    • 33747819585 scopus 로고    scopus 로고
    • Clinicopathologic significance of the basal-like subtype of breast cancer: A comparison with hormone receptor and Her2/neuoverexpressing phenotypes
    • Kim M.J., Ro J.Y., Ahn S.H., Kim H.H., Kim S.B. and Gong G. (2006). Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neuoverexpressing phenotypes. Hum. Pathol. 37, 1217-1226.
    • (2006) Hum. Pathol , vol.37 , pp. 1217-1226
    • Kim, M.J.1    Ro, J.Y.2    Ahn, S.H.3    Kim, H.H.4    Kim, S.B.5    Gong, G.6
  • 17
    • 3142559728 scopus 로고    scopus 로고
    • Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation
    • Langner C., Ratschek M., Rehak P., Schips L. and Zigeuner R. (2004). Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation? J. Clin. Pathol. 57, 773-775.
    • (2004) J. Clin. Pathol , vol.57 , pp. 773-775
    • Langner, C.1    Ratschek, M.2    Rehak, P.3    Schips, L.4    Zigeuner, R.5
  • 20
    • 65849527304 scopus 로고    scopus 로고
    • An overview of the epidermal growth factor receptor fluorescence in situ hybridisation challenge in tumour pathology
    • Martin V., Mazzucchelli L. and Frattini M. (2009). An overview of the epidermal growth factor receptor fluorescence in situ hybridisation challenge in tumour pathology. J. Clin. Pathol. 62, 314-324.
    • (2009) J. Clin. Pathol , vol.62 , pp. 314-324
    • Martin, V.1    Mazzucchelli, L.2    Frattini, M.3
  • 25
    • 67049119497 scopus 로고    scopus 로고
    • Basal-like breast carcinoma: From expression profiling to routine practice
    • Rakha E. and Reis-Filho J.S. (2009). Basal-like breast carcinoma: from expression profiling to routine practice. Arch. Pathol. Lab. Med. 133, 860-868.
    • (2009) Arch. Pathol. Lab. Med , vol.133 , pp. 860-868
    • Rakha, E.1    Reis-Filho, J.S.2
  • 27
    • 45149094267 scopus 로고    scopus 로고
    • Basal-like breast cancer: A critical review
    • Rakha E.A, Reis-Filho J.S. and Ellis I.O. (2008). Basal-like breast cancer: a critical review. J. Clin. Oncol. 26, 2568-2581.
    • (2008) J. Clin. Oncol , vol.26 , pp. 2568-2581
    • Rakha, E.A.1    Reis-Filho, J.S.2    Ellis, I.O.3
  • 33
    • 70349939382 scopus 로고    scopus 로고
    • Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer
    • Siena S., Sartore-Bianchi A., Di Nicolantonio F., Balfour J. and Bardelli A. (2009). Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J. Natl. Cancer Inst. 101, 1308-1324.
    • (2009) J. Natl. Cancer Inst , vol.101 , pp. 1308-1324
    • Siena, S.1    Sartore-Bianchi, A.2    di Nicolantonio, F.3    Balfour, J.4    Bardelli, A.5
  • 37
    • 34248147439 scopus 로고    scopus 로고
    • Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: The EGFR fluorescence in situ hybridization assay
    • Varella-Garcia M. (2006). Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay. Diagn. Pathol. 1, 19.
    • (2006) Diagn. Pathol , vol.1 , pp. 19
    • Varella-Garcia, M.1
  • 39
    • 84859314389 scopus 로고    scopus 로고
    • Registry of clinical trials
    • www.clinicaltrial.gov; Registry of clinical trials.
  • 40
    • 84859348994 scopus 로고    scopus 로고
    • COSMIC: Catalogue Of Somatic Mutations In Cancer
    • www.sanger.ac.uk/genetics/CGP/cosmic; COSMIC: Catalogue Of Somatic Mutations In Cancer.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.